Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
A Phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma
Ongoing research continues to evaluate sterile solvent systems and preservative-containing aqueous solutions in controlled laboratory environments, including their influence on experimental reproducibility and contamination prevention
The verification key resolves at janoshik.com to confirm the COA's authenticity
These properties were the basis for its original development as a candidate obesity drug
Verified Customer So Far, So Good
US$ 21.41
US$ 21.70
US$ 26.20
US$ 24.72
US$ 20.18
US$ 20.60
US$ 23.69
US$ 29.13
US$ 28.96
US$ 23.04
